Pnc Financial Services »

Aardvark Therapeutics shares owned by Pnc Financial Services

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Pnc Financial Services from 13F filings

Historical chart of Pnc Financial Services investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Pnc Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Pnc Financial Services

Quarter filed Position value Share count Share price at filing
2026-03-31 $105 28 3.79
2025-09-30 $1.9k 140 13.29

More positions owned by Pnc Financial Services

Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Et (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Exxon Mobil Corporation (XOM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
Amazon (AMZN)
Johnson & Johnson (JNJ)
Ishares Tr Core Msci Intl (IDEV)

View all positions for Pnc Financial Services

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
BlackRock
Vanguard Group
Vanguard Capital Management
Polygon Management
Geode Capital Management
Silverarc Capital Management
Two Sigma Investments
State Street Corporation
UBS Group
AQR Capital Management
Millennium Management
Northern Trust

View all funds holding Aardvark Therapeutics